Trial · NCT00600886
Participant flow40
How many started, completed or left each group, period by period.
1 to 20 of 40
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Core Phase - Full Analysis Set (FAS) | STARTED | Pasireotide LAR | 176 | |
| Core Phase - Full Analysis Set (FAS) | STARTED | Octreotide LAR | 182 | |
| Core Phase - Full Analysis Set (FAS) | Did Not Enter Extension | Pasireotide LAR | 29 | |
| Core Phase - Full Analysis Set (FAS) | Did Not Enter Extension | Octreotide LAR | 29 | |
| Core Phase - Full Analysis Set (FAS) | Entered Extension, Crossed Over | Pasireotide LAR | 38 | |
| Core Phase - Full Analysis Set (FAS) | Entered Extension, Crossed Over | Octreotide LAR | 81 | |
| Core Phase - Full Analysis Set (FAS) | Entered Ext Continued Same Treatment | Pasireotide LAR | 74 | |
| Core Phase - Full Analysis Set (FAS) | Entered Ext Continued Same Treatment | Octreotide LAR | 46 | |
| Core Phase - Full Analysis Set (FAS) | COMPLETED | Pasireotide LAR | 141 | |
| Core Phase - Full Analysis Set (FAS) | COMPLETED | Octreotide LAR | 156 | |
| Core Phase - Full Analysis Set (FAS) | NOT COMPLETED | Pasireotide LAR | 35 | |
| Core Phase - Full Analysis Set (FAS) | NOT COMPLETED | Octreotide LAR | 26 | |
| Extension - Same Treatment (FAS) | STARTED | Pasireotide LAR | 74 | |
| Extension - Same Treatment (FAS) | STARTED | Octreotide LAR | 46 | |
| Extension - Same Treatment (FAS) | Completed Study at Month 26 | Pasireotide LAR | 0 | |
| Extension - Same Treatment (FAS) | Completed Study at Month 26 | Octreotide LAR | 31 | |
| Extension - Same Treatment (FAS) | Completed Study After Month 26 | Pasireotide LAR | 28 | |
| Extension - Same Treatment (FAS) | Completed Study After Month 26 | Octreotide LAR | 4 | |
| Extension - Same Treatment (FAS) | Discontinued After Month 26 | Pasireotide LAR | 23 | |
| Extension - Same Treatment (FAS) | Discontinued After Month 26 | Octreotide LAR | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00600886/flow